Government Proposal to Legalize E-cigarette Sales Sparks Medical Concern

Aug.20.2024
Government Proposal to Legalize E-cigarette Sales Sparks Medical Concern
Brazilian senator Soraya Thronicke's proposal to legalize e-cigarette sales will be debated in the Senate, sparking medical entities' opposition.

According to Tnonline on August 19th, Brazilian Senator Soraya Thronicke proposed a bill to allow for the commercial sale of e-cigarettes. After multiple delays, the bill is now on the agenda for the Senate's Economic Affairs Committee (CAE) on August 20th, sparking concern from 80 medical entities opposed to the proposal.


In a statement led by the Brazilian Medical Association (AMB) and the Brazilian Society of Pulmonology and Tuberculosis (SBPT), these organizations strongly reaffirmed their opposition to changes in e-cigarette regulation.


Dr. Ricardo Meirelles, coordinator of the AMB Smoking Control Committee, stated that,...


This proposal is irresponsible towards the Brazilian people, as it aims to open up the sale of a harmful product to public health.


In April of this year, Anvisa unanimously decided to continue to ban the manufacturing, importation, and sale of e-cigarette products in Brazil. However, if the bill is approved in the Senate, it will be directly sent to the House of Representatives for review without requiring Anvisa's approval.


Soraya's proposal argues that the initial ban was based on a principle of public health supervision - the precautionary principle - because at that time there was little understanding of these products. Since then, despite not being approved, the use of e-cigarettes has increased, preventing sales is like "closing one's eyes to reality". In her proposal written in 2023, she emphasizes that.


The ban failed to address the issue, strict sales rules need to be established.


She compared Anvisa's resolution with the approval of the US FDA.


If the proposal is passed, e-cigarettes will be taxed. According to lawmakers in support of the proposal, it is estimated that the tax revenue could reach 22 billion Brazilian Reais (4.06 billion US dollars) annually. However, the medical community argues that this amount is not enough to cover the medical expenses resulting from an increase in respiratory diseases. In 2022 alone, Brazil has already spent 153.5 billion Reais (283.8 billion US dollars) on healthcare costs and lost productivity caused by tobacco use.


Paulo César Rodrigues Pinto Correa, coordinator of the SBPT Research Committee, highlighted the political manipulation surrounding the issue of e-cigarettes and emphasized the need for increased regulation and measures to combat illegal sales. Otherwise, the increase in illegal sales will continue to be used as an excuse to support attempts to lift the ban.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Kenyan Bar Owners and Retailers Petition Senate to Halt Debate on Tobacco Control (Amendment) Bill 2024, Citing Lack of Public Consultation and Potential Job Losses
Kenyan Bar Owners and Retailers Petition Senate to Halt Debate on Tobacco Control (Amendment) Bill 2024, Citing Lack of Public Consultation and Potential Job Losses
Kenyan bar and retail owners petition Senate to halt debate on Tobacco Control (Amendment) Bill 2024 due to concerns.
Sep.26 by 2FIRSTS.ai
Spain’s Vape Bill Clears EU Internal Market Review, Moves to Parliament
Spain’s Vape Bill Clears EU Internal Market Review, Moves to Parliament
Spain’s draft reform of its tobacco law has reached a critical stage. 2Firsts recently confirmed with Spanish government sources that the bill has completed the EU’s internal market review process and was approved by the Council of Ministers in early September. The decision means that, despite objections from the European Commission and several member states, Spain maintained its original provisions and has now moved the draft into parliamentary debate.
Sep.30
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai
Russian Lawmaker Sounds Alarm as Teenage Vaping Surges—Female Use Overtakes Male
Russian Lawmaker Sounds Alarm as Teenage Vaping Surges—Female Use Overtakes Male
Russia’s Chair of the State Duma Committee on Youth Policy warns that among 11–14-year-olds, girls now vape at higher rates than boys, a trend he calls “deeply concerning.” He says the spread of nicotine products—especially e-cigarettes—among minors poses a public health risk and warrants continued policy-level interventions.
Oct.17 by 2FIRSTS.ai
COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms
COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms
The 11th Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) will be held in Geneva, Switzerland, from November 7 to 22, 2025. The meeting is expected to focus on the disclosure of tobacco constituents, environmental impacts, and industry responsibility. South Korea plans to implement the Tobacco Harmfulness Management Act in November and is preparing to send a delegation to COP11 to help align domestic regulations with international standards.
Sep.05 by 2FIRSTS.ai
InterTabac 2025 Insights|Brands like NYSM and KIWI are promoting small-sized e-cigarettes, none of which feature screens
InterTabac 2025 Insights|Brands like NYSM and KIWI are promoting small-sized e-cigarettes, none of which feature screens
Inter Tabac 2025, held in Dortmund, Germany, took place from September 18th to 20th. 2Firsts observed that some booths, including those of NYSM, KIWI, Mevol, and FLERBAR, showcased small e-cigarettes. These devices were smaller or thinner than traditional disposable or cartridge-based e-cigarettes and lacked screen functionality.
Sep.23 by 2FIRSTS.ai